MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common...
$670K
Net cash provided by
financing activities
$124K
Canceled cashflow
$546K
Net decrease in
cash, cash...
-$9,322K
Canceled cashflow
$124K
something is missing
$31,732K
Prepaid expenses and
other assets-Related...
-$4,573K
Operating lease
right-of-use assets
-$1,687K
Stock-based compensation
$1,551K
Depreciation
$904K
Accounts payable
$570K
Accrued expenses and
other current...
$308K
Prepaid expenses and
other...
-$217K
Accounts
receivable-Related Party
-$49K
Accounts
receivable-Nonrelated Party
-$12K
something is missing
-$534K
Payment of issuance
costs
$12K
Net cash used in
operating activities
-$9,446K
Canceled cashflow
$41,603K
Net loss
-$46,971K
Operating lease
liabilities
-$3,418K
Genefab sublease
deferred income - related...
-$660K
Back
Back
Cash Flow
source: myfinsight.com
Senti Biosciences, Inc. (SNTI)
Senti Biosciences, Inc. (SNTI)